Format

Send to

Choose Destination
BMJ Evid Based Med. 2019 Jun;24(3):99-102. doi: 10.1136/bmjebm-2018-111110. Epub 2018 Dec 10.

Updated 2018 NICE guideline on pharmacological treatments for people with ADHD: a critical look.

Author information

1
Psychiatric Research Unit, Region Zealand Psychiatry, Slagelse, Denmark.
2
Islington Child and Adolescent Mental Health Service, Whittington Health NHS Trust, London, UK.
3
Unit of Clinical Pharmacology, TransLab Research Group, Department of Medical Sciences, Universitat de Girona, Girona, Spain.
4
Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
5
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
6
Department of Psychology, University of Southern Denmark, Odense, Denmark.

KEYWORDS:

clinical pharmacology; mental health

PMID:
30530806
DOI:
10.1136/bmjebm-2018-111110

Conflict of interest statement

Competing interests: CG, OJS, MZ and ES have authored two of the Cochrane reviews on methylphenidate for ADHD, and XC has authored two of the Cochrane reviews on amphetamines for ADHD. MZ is a clinician working with patients with ADHD and prescribes stimulant medications regularly.

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center